1、临床试验Arsenic Trioxide in Refractory Solid Tumors with Rescuable p53 Mutation (https://www.clinicaltrials.gov/ct2/show/NCT04869475)

2、临床试验Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS (https://www.clinicaltrials.gov/ct2/show/NCT03855371)

3、临床试验Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations (https://www.clinicaltrials.gov/ct2/show/NCT04906031)

4、TP53 Trust介绍（http://tp53.co.uk/interview-with-min-lu/）

5、AntiCancer Fund介绍（https://www.anticancerfund.org/en/blog/latest-news-about-drug-repurposing-oncology-4）